Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|January 18, 2021
Cultivation of aerobic granular sludge for the treatment of food-processing wastewater and the impact on membrane filtration propertiesH Stes, M Caluwé, L Dockx, et al.Applied Microbiology and Biotechnology|December 13, 2017
Cofactor F430 as a biomarker for methanogenic activity: application to an anaerobic bioreactor systemI Passaris, P Van Gaelen, R Cornelissen, et al.Acta Neurologica Belgica|July 16, 2020
Community-acquired bacterial meningitis in adults: emergency department management protocolI Smets, S Verelst, G Meyfroidt, et al.Acta Neurologica Belgica|April 10, 2017
Corticosteroids in the management of acute multiple sclerosis exacerbationsI Smets, L Van Deun, C Bohyn, et al.Water Science and Technology : a Journal of the International Association on Water Pollution Research|September 26, 2018
Application of online instrumentation in industrial wastewater treatment plants - a survey in Flanders, BelgiumR Cornelissen, T Van Dyck, J Dries, et al.Water Science and Technology : a Journal of the International Association on Water Pollution Research|April 16, 2020
Position paper - progress towards standards in integrated (aerobic) MBR modellingC Brepols, J Comas, J Harmand, et al.Water Research|November 23, 2024
Modeling MBR fouling: A critical review analysis towards establishing a framework for good modeling practicesV Sandoval-García, M V Ruano, M Alliet, et al.Multiple Sclerosis and Related Disorders|May 28, 2021
Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosisK Allen-Philbey, A Stennett, T Begum, et al.Multiple Sclerosis and Related Disorders|July 11, 2022
Did it hurt? COVID-19 vaccination experience in people with multiple sclerosisK Allen-Philbey, A Stennett, T Begum, et al.Multiple Sclerosis and Related Disorders|October 6, 2024
The recurrence of disease activity after ocrelizumab discontinuation in multiple sclerosisE Coerver, L Schoof, L Hogenboom, et al.Pageof 2